These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Unspecific effects of certain siRNA molecules used in the treatment of age related macular degeneration]. Ebbesen M; Bek T; Pedersen FS; Jensen TG Ugeskr Laeger; 2010 Sep; 172(36):2457-9. PubMed ID: 20825735 [TBL] [Abstract][Full Text] [Related]
4. Efficient delivery of siRNA by atelocollagen in a murine laser-induced choroidal neovascularization model. Ito Y; Nozaki M; Sugitani K; Ashikari M; Hirano Y; Ogura Y Ophthalmologica; 2013; 230(4):215-21. PubMed ID: 24080835 [TBL] [Abstract][Full Text] [Related]
5. Small interfering RNAs induce target-independent inhibition of tumor growth and vasculature remodeling in a mouse model of hepatocellular carcinoma. Bergé M; Bonnin P; Sulpice E; Vilar J; Allanic D; Silvestre JS; Lévy BI; Tucker GC; Tobelem G; Merkulova-Rainon T Am J Pathol; 2010 Dec; 177(6):3192-201. PubMed ID: 20971743 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA. Gu L; Chen H; Tuo J; Gao X; Chen L Exp Eye Res; 2010 Sep; 91(3):433-9. PubMed ID: 20599960 [TBL] [Abstract][Full Text] [Related]
7. Small interfering RNA-induced TLR3 activation inhibits blood and lymphatic vessel growth. Cho WG; Albuquerque RJ; Kleinman ME; Tarallo V; Greco A; Nozaki M; Green MG; Baffi JZ; Ambati BK; De Falco M; Alexander JS; Brunetti A; De Falco S; Ambati J Proc Natl Acad Sci U S A; 2009 Apr; 106(17):7137-42. PubMed ID: 19359485 [TBL] [Abstract][Full Text] [Related]
9. Suppression of laser-induced choroidal neovascularization by nontargeted siRNA. Ashikari M; Tokoro M; Itaya M; Nozaki M; Ogura Y Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3820-4. PubMed ID: 20130283 [TBL] [Abstract][Full Text] [Related]
10. Chemical modifications on siRNAs avoid Toll-like-receptor-mediated activation of the hepatic immune system in vivo and in vitro. Broering R; Real CI; John MJ; Jahn-Hofmann K; Ickenstein LM; Kleinehr K; Paul A; Gibbert K; Dittmer U; Gerken G; Schlaak JF Int Immunol; 2014 Jan; 26(1):35-46. PubMed ID: 24065781 [TBL] [Abstract][Full Text] [Related]
11. Development of gene therapy for treatment of age-related macular degeneration. Askou AL Acta Ophthalmol; 2014 Jul; 92 Thesis3():1-38. PubMed ID: 24953666 [TBL] [Abstract][Full Text] [Related]
12. VEGFA Gene Silencing in CXCR4-Expressing Cells via siRNA Delivery by Means of Targeted Peptide Carrier. Egorova AA; Maretina MA; Kiselev AV Methods Mol Biol; 2019; 1974():57-68. PubMed ID: 31098995 [TBL] [Abstract][Full Text] [Related]
13. Morpholino-mediated increase in soluble Flt-1 expression results in decreased ocular and tumor neovascularization. Owen LA; Uehara H; Cahoon J; Huang W; Simonis J; Ambati BK PLoS One; 2012; 7(3):e33576. PubMed ID: 22438952 [TBL] [Abstract][Full Text] [Related]
14. Role of small interfering RNA (siRNA) in targeting ocular neovascularization: A review. Supe S; Upadhya A; Singh K Exp Eye Res; 2021 Jan; 202():108329. PubMed ID: 33198953 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic effects of a novel siRNA-based anti-VEGF (siVEGF) nanoball for the treatment of choroidal neovascularization. Ryoo NK; Lee J; Lee H; Hong HK; Kim H; Lee JB; Woo SJ; Park KH; Kim H Nanoscale; 2017 Oct; 9(40):15461-15469. PubMed ID: 28976519 [TBL] [Abstract][Full Text] [Related]